Real clinical practice and contraception for young women with children
The review presents the psychosocial characteristics of young women in todays millennial generation and survey data regarding their hormonal contraceptive requirements. The results of randomized clinical trials and real-life studies of the use of the combined oral contraceptive (COC) Qlaira containi...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Berlin A.V.
2021-03-01
|
Series: | Гинекология |
Subjects: | |
Online Access: | https://gynecology.orscience.ru/2079-5831/article/viewFile/63626/pdf |
_version_ | 1818906507836653568 |
---|---|
author | Natalia V. Aganezova Sergey S. Aganezov |
author_facet | Natalia V. Aganezova Sergey S. Aganezov |
author_sort | Natalia V. Aganezova |
collection | DOAJ |
description | The review presents the psychosocial characteristics of young women in todays millennial generation and survey data regarding their hormonal contraceptive requirements. The results of randomized clinical trials and real-life studies of the use of the combined oral contraceptive (COC) Qlaira containing estradiol valerate and dienogest (E2V/DNG) in a dynamic dosing regimen were analyzed, in which the reliability of the contraceptive effect of the drug was identified and confirmed, the restoration of fertility was population level after drug withdrawal, its minimal effect on metabolism and a reduced risk of cardiovascular complications (venous and arterial thrombosis) when using Qlaira COC in comparison with other COCs. The absence of a negative effect of COC E2V/DNG on body weight, sexual function and vaginal microbiocenosis in most women has been proven. The data on satisfactory characteristics of menstrual bleeding (lighter and shorter) in users of Qlaira COC and a decrease in symptoms associated with a hormone-free interval, which often occur when taking other COCs in the 21/7 regimen, are presented. The favorable efficacy and safety profile of COC E2V/DNG in real conditions, the advantages of estrogen bioidentical to the endogenous, in the composition of the drug, the dosage regimen 26/2, the positive effect on the lifestyle, determine the significant satisfaction of young women, including young women with children, and the ability to use the drug for a long time until menopause. |
first_indexed | 2024-12-19T21:40:20Z |
format | Article |
id | doaj.art-d4216e3663d249609119084ebd9aa633 |
institution | Directory Open Access Journal |
issn | 2079-5696 2079-5831 |
language | Russian |
last_indexed | 2024-12-19T21:40:20Z |
publishDate | 2021-03-01 |
publisher | IP Berlin A.V. |
record_format | Article |
series | Гинекология |
spelling | doaj.art-d4216e3663d249609119084ebd9aa6332022-12-21T20:04:41ZrusIP Berlin A.V.Гинекология2079-56962079-58312021-03-01231253210.26442/20795696.2021.1.20062958264Real clinical practice and contraception for young women with childrenNatalia V. Aganezova0https://orcid.org/0000-0002-9676-1570Sergey S. Aganezov1https://orcid.org/0000-0002-3523-9922Mechnikov North-Western State Medical UniversityMechnikov North-Western State Medical UniversityThe review presents the psychosocial characteristics of young women in todays millennial generation and survey data regarding their hormonal contraceptive requirements. The results of randomized clinical trials and real-life studies of the use of the combined oral contraceptive (COC) Qlaira containing estradiol valerate and dienogest (E2V/DNG) in a dynamic dosing regimen were analyzed, in which the reliability of the contraceptive effect of the drug was identified and confirmed, the restoration of fertility was population level after drug withdrawal, its minimal effect on metabolism and a reduced risk of cardiovascular complications (venous and arterial thrombosis) when using Qlaira COC in comparison with other COCs. The absence of a negative effect of COC E2V/DNG on body weight, sexual function and vaginal microbiocenosis in most women has been proven. The data on satisfactory characteristics of menstrual bleeding (lighter and shorter) in users of Qlaira COC and a decrease in symptoms associated with a hormone-free interval, which often occur when taking other COCs in the 21/7 regimen, are presented. The favorable efficacy and safety profile of COC E2V/DNG in real conditions, the advantages of estrogen bioidentical to the endogenous, in the composition of the drug, the dosage regimen 26/2, the positive effect on the lifestyle, determine the significant satisfaction of young women, including young women with children, and the ability to use the drug for a long time until menopause.https://gynecology.orscience.ru/2079-5831/article/viewFile/63626/pdfyoung women with childrenmillennials generationcombined oral contraceptivesestradiol valeratedienogestqlaira |
spellingShingle | Natalia V. Aganezova Sergey S. Aganezov Real clinical practice and contraception for young women with children Гинекология young women with children millennials generation combined oral contraceptives estradiol valerate dienogest qlaira |
title | Real clinical practice and contraception for young women with children |
title_full | Real clinical practice and contraception for young women with children |
title_fullStr | Real clinical practice and contraception for young women with children |
title_full_unstemmed | Real clinical practice and contraception for young women with children |
title_short | Real clinical practice and contraception for young women with children |
title_sort | real clinical practice and contraception for young women with children |
topic | young women with children millennials generation combined oral contraceptives estradiol valerate dienogest qlaira |
url | https://gynecology.orscience.ru/2079-5831/article/viewFile/63626/pdf |
work_keys_str_mv | AT nataliavaganezova realclinicalpracticeandcontraceptionforyoungwomenwithchildren AT sergeysaganezov realclinicalpracticeandcontraceptionforyoungwomenwithchildren |